Navigation Links
New Rotavirus vaccine joins routine infant immunization schedule

The federal agency that oversees childhood vaccinations today recommended a new vaccine for routine use against rotavirus infection, a common childhood illness that is the single largest infectious disease killer of infants and young children worldwide. Three scientists associated with The Children's Hospital of Philadelphia and The Wistar Institute are co-inventors of the vaccine, based on research dating to 1980.

Meeting today in Atlanta, the Advisory Committee on Immunization Practices (ACIP), an expert panel selected by the U.S. Department of Health and Human Services, added the new RotaTeq vaccine, manufactured by Merck & Co., Inc., to its list of routinely recommended childhood immunizations. Today's decision follows the vaccine's approval for licensing earlier this month by the U.S. Food and Drug Administration.

Rotavirus affects nearly all children at some point, often with mild symptoms, but in other cases with severe and potentially life-threatening diarrhea and dehydration. It causes tens of thousands of hospitalizations in the U.S. each year, and throughout the world, hundreds of thousands of child deaths.

The new vaccine was invented by three Philadelphia scientists: H. Fred Clark, D.V.M., Ph.D.; Paul A. Offit, M.D.; and Stanley A. Plotkin, M.D., all of whom led laboratory studies of the vaccine at The Children's Hospital of Philadelphia and The Wistar Institute between 1980 and 1991. Since 1991, the vaccine has been developed for commercial use by Merck, which conducted extensive clinical trials.

Dr. Offit is currently chief of Infectious Diseases, Maurice R. Hilleman Endowed Chair in Vaccinology, and director of the Vaccine Education Center at The Children's Hospital of Philadelphia. Dr. Clark is a research professor of Pediatrics at Children's Hospital. Dr. Plotkin, an emeritus professor at Wistar and a former director of Infectious Diseases at Children's Hospital, developed a number of previous vaccines, includ
'"/>

Source:Children's Hospital of Philadelphia


Page: 1 2

Related biology news :

1. Rotavirus can spread beyond the intestine
2. Research advances quest for HIV-1 vaccine
3. A much-needed shot in the arm for HIV vaccine development
4. Discovery of key proteins shape could lead to improved bacterial pneumonia vaccine
5. Gene vaccine for Alzheimers disease shows promising results
6. Influenza vaccine uses insect cells to speed development
7. Norovirus, AIDS vaccine and Hepatitis Virus
8. HIV vaccine trial breaks ground for future research
9. Live vaccines more effective against horse herpes virus
10. NIAID begins clinical trial of West Nile virus vaccine
11. Designing vaccines by computer

Post Your Comments:
(Date:11/24/2009)...titutes fish food is a matter of debate. A high-pr...t almost 50 percent of their carbon from trees and...e terrestrial and aquatic ecosystems. , But new ...his is not likely to be true. Algae provide a much...rding to research published this week in the Proc...
(Date:11/23/2009)..., D.C. The community-associated strain of the dea...istant to most common antibioticsposes a far great...ng its way into hospitals, according to a study in...es . , The new threat is easily picked up in fi...d has increased the overall burden of MRSA within ...
(Date:11/23/2009)...lif. -- More than 160 participants gathered this w... FUTURES INITIATIVE conference. This year,s topic,... engineers, and medical researchers to explore the...nding the emerging field of synthetic biology. , ... at Princeton University and this year,s conferenc...
Breaking Biology News(10 mins):Fish food fight: Fish don't eat trees after all, says new study 2Fish food fight: Fish don't eat trees after all, says new study 3New study finds MRSA on the rise in hospital outpatients 2Synthetic biology offers new opportunities for interdisciplinary collaboration 2Parents Guide to Cord Blood Foundation Introduces New Brochure During Cord Blood Awareness Month to Address Critical Education Gap 50861 1Parents Guide to Cord Blood Foundation Introduces New Brochure During Cord Blood Awareness Month to Address Critical Education Gap 50861 2Parents Guide to Cord Blood Foundation Introduces New Brochure During Cord Blood Awareness Month to Address Critical Education Gap 50861 3Urgent 28R 29 PC and Macroplastique 28R 29 Featured in Numerous IUGA 2009 Sessions 50859 1Urgent 28R 29 PC and Macroplastique 28R 29 Featured in Numerous IUGA 2009 Sessions 50859 2Urgent 28R 29 PC and Macroplastique 28R 29 Featured in Numerous IUGA 2009 Sessions 50859 3Urgent 28R 29 PC and Macroplastique 28R 29 Featured in Numerous IUGA 2009 Sessions 50859 4Video 3A FDA Approves Hologics Adiana 28R 29 Permanent Contraception System 50858 1Video 3A FDA Approves Hologics Adiana 28R 29 Permanent Contraception System 50858 2Video 3A FDA Approves Hologics Adiana 28R 29 Permanent Contraception System 50858 3Video 3A FDA Approves Hologics Adiana 28R 29 Permanent Contraception System 50858 4Video 3A FDA Approves Hologics Adiana 28R 29 Permanent Contraception System 50858 5
... A new study provides the first evidence that peop...eater response to ozone than leaner people. Short...known to cause a temporary drop in lung function i...o look at whether body weight influenced how much ...one is formed in the atmosphere in the presence of...
... Cambridge researchers have discovered that indivi... their close family members have distinctive patte...ime that scientists have associated an anatomical ...e new findings, reported today in the journal Brai...isk of developing OCD and lead to more accurate di...
... The world-renowned evolutionary scientist Niles E...cience teacher, believe it,s time to help science ...reationists exert on public education. So they joi...and, on Darwin,s birthday in February this year, a...: Education and Outreach. , The print version wil...
Other Biology News:Ozone can affect heavier people more 2Ozone can affect heavier people more 3Brain pattern associated with genetic risk of obsessive compulsive disorder 2An intelligent new way to support the teaching of evolution 2
(Date:11/24/2009)..., SANMATEO,Calif.,Nov.24/PRNewswire-FirstCall...lcompanyfocusedondevelopingandcommercializingnovel...iTonno,PresidentandChiefExecutiveOfficer,isschedul...nference,tobeheldDecember1-2,2009atTheNewYorkPalac...nGhiglieri,ChiefFinancialOfficer,willbeavailableto...
(Date:11/24/2009)..., ,Primaryefficacyendpointhasbeenmetforpatient..., QUEBECCITY,Nov.24/PRNewswire-FirstCall/-AEt...y"),aglobalbiopharmaceuticalcompanyfocusedonendocr...cydatafromaPhase2studywithitstargetedcytotoxicpept...thadvancedorrecurrentendometrialcancer.Inapersonal...
(Date:11/24/2009)..., REDWOODCITY,Calif.,Nov.24/PRNewswire-FirstC...cedthatRandyScott,GenomicHealth,sExecutiveChairman...onferenceinNewYorkCityonTuesday,December1,2009at10...hivedwebcastofthepresentation,visittheInvestorRela...stor.genomichealth.com .Pleaseconnecttothewebsitea...
(Date:11/24/2009)..., SEATTLE,Nov.24/PRNewswire-FirstCall/--CellT...willpresentatthe21stAnnualPiperJaffrayHealthCareCo...ttheNewYorkPalaceHotel. ,, CTIwillpresentonTues...oor).AliveaudiowebcastofCTI,spresentationwillbeava...availableforreplayafterwards. , ,PiperJaffrayHeal...
Breaking Biology Technology:NeurogesX to Present at Piper Jaffray Health Care Conference 2NeurogesX to Present at Piper Jaffray Health Care Conference 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 4Genomic Health to Present at Piper Jaffray Health Care Conference 2
...Milwaukee, Wis. - The National Cancer Institute ...nt to the Medical College of Wisconsin to study ...is is the second successful renewal of the grant t... associate professor of radiology, is the ongoing ...tors are developing what they call magnetic resona...
...Editor,s note: This is the ninth in a series of ar...hnology or biotechnology sectors. The most recent ...adison, Wis. - The idea is developed. Lawyers and...ty has been protected. The entity is formed. The n...ounders, have been hired and independent contracto...
...Madison, Wis. - About five weeks after the launch... several would-be customers still expressed a pref...ffee shops. , ,Now, Mad City Broadband , which pr...ius of Madison,s Capitol Square and at Dane Count...ut of them. The broadband service will add indoor ...
Other Biology Technology:Early Stage, Step 9: Raising capital in the securities landscape 2Early Stage, Step 9: Raising capital in the securities landscape 3Early Stage, Step 9: Raising capital in the securities landscape 4
Bovine Phosphatase, Alkaline bovine intestinal mucosa, Unconjugated from Sigma-Aldrich
...T siRNA Tracker Intracellular Localization Kit wit...straight forward approach to directly label and de...on-destructive manner, for in vitro tracking exper...hibition of target gene expression can be monitore...
...ied MW: 60kDa (A) and 36kDa (C) subunits Formulati...0mM 2-mercaptoethanol, 1mM MgCl2, 1mM EGTA, 0.1mM ...es: For selective in vitro dephosphorylation of pr...xyl-agarose and gel filtration chromatography Qual...
...reparative LC/MS, using mass numbers as a trigger,...eal for performing investigation and research of n... both analytical and preparative operation. Switch...tware. This support provides a quick solution for ...
Biology Products: